If UK leaves EU without reaching an agreement how will this impact your business? If your business is to supply UK and / or EU with licensed (bio)pharmaceutical products ? do you have everything in place for all possible scenarios?
Whatever regulatory and quality-related hurdles await you, Tentamus Pharma services have the solution to get you through the Brexit uncertainty. With dedicated facilities in the UK and several mainland Europe laboratories we can take care of all your analytical dilemmas and challenges ? such batch release testing, stability studies, method validation & transfer, bioanalytical services, microbiological and molecular-biological control.
It?s still not too late to start planning your activities.
Tentamus Pharma Group ? Brexit Services
EU / UK Analytical Support of a variety of products and starting materials
Small molecules & biologics
Compendial methods
Analytical Method Transfer (AMT) and Validations
Batch Release Services
QP Services
Regulatory Support / Advice
Audits & Quality visits
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
www.tentamus.com